Polygenic score modifies risk for Alzheimer's disease in ε4 homozygotes at phenotypic extremes.

TitlePolygenic score modifies risk for Alzheimer's disease in ε4 homozygotes at phenotypic extremes.
Publication TypeJournal Article
Year of Publication2021
AuthorsHuq AJ, Fulton-Howard B, Riaz M, Laws S, Sebra R, Ryan J, Renton AE, Goate AM, Masters CL, Storey E, Shah RC, Murray A, McNeil J, Winship I, James PA, Lacaze P
Corporate AuthorsAlzheimer's Disease Genetics Consortium
JournalAlzheimers Dement (Amst)
Volume13
Issue1
Paginatione12226
Date Published08/2021
ISSN2352-8729
Abstract

Introduction: Diversity in cognition among apolipoprotein E () ε4 homozygotes can range from early-onset Alzheimer's disease (AD) to a lifetime with no symptoms.

Methods: We evaluated a phenotypic extreme polygenic risk score (PRS) for AD between cognitively healthy ε4 homozygotes aged ≥75 years (n = 213) and early-onset ε4 homozygote AD cases aged ≤65 years (n = 223) as an explanation for this diversity.

Results: The PRS for AD was significantly higher in ε4 homozygote AD cases compared to older cognitively healthy ε4/ε4 controls (odds ratio [OR] 8.39; confidence interval [CI] 2.0-35.2;  = .003). The difference in the same PRS between ε3/ε3 extremes was not as significant (OR 3.13; CI 0.98-9.92;  = .053) despite similar numbers and power. There was no statistical difference in an educational attainment PRS between these age extreme case-controls.

Discussion: A PRS for AD contributes to modified cognitive expression of the ε4/ε4 genotype at phenotypic extremes of risk.

DOI10.1002/dad2.12226
Alternate JournalAlzheimers Dement (Amst)
PubMed ID34386572
PubMed Central IDPMC8339682
Grant ListU01 AG032984 / AG / NIA NIH HHS / United States
U01 AG052411 / AG / NIA NIH HHS / United States